You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Turkey

Apr 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health demonstrates positive growth in 2011

In 2011, consumer health registered stronger value growth compared to the CAGR seen over the review period. Improved economic conditions in the country were among the most important reasons for growth. Additionally, the lifting of the ban on the import of products containing GMO (genetically modified organisms) in mid-2010 also affected the category positively in areas such as weight management, sports nutrition, vitamins and dietary supplements and herbal/traditional products. The ban was implemented by the Government from 2009 to mid-2010. Rising urbanisation was also a very important factor for growth as the consumption of a number of products, such as vitamins and dietary supplements and NRT smoking cessation aids, is higher in urban areas.

Long-awaited OTC legislation is still to be introduced

At the end of the review period, the long-awaited OTC legislation was still not introduced, despite the fact that companies active within consumer health have been looking forward to this legislation. The legislation is expected to bring about fundamental structural changes in the market as it involves an expanded list of OTC products that are not reimbursed by the social security system. With the introduction of the OTC legislation, many products are expected to be switched from prescription to non-prescription; these products can be freely advertised and sold in the grocery retailers channel. However, pharmacists and doctors associations strongly disagree with the proposed changes and argue that all products related to health should be sold under the supervision of health professionals. The legislation is expected to be introduced early in the forecast period.

Multinational companies lead

In 2011, consumer health was led by multinational companies. The top three companies were Bayer Türk Kimya Sanayi Ltd Sti, Herbalife International Urunleri Ticaret Ltd Sti and Sandoz Ilac ve Tic AS. Local companies, on the other hand, were strong in more specific product areas such as hair loss treatments. In other categories, local players produced generic products. The leading local companies were Dogadan Gida Urunleri San ve Paz AS, present within slimming teas, and Abdi Ibrahim Ilaç Sanayi ve Ticaret AS, which is present in a range of categories, including medicated skin care and vitamins and dietary supplements.

Chemists/pharmacies is the dominant distribution channel

In 2011, chemists/pharmacies remained in a dominant position in the sales of consumer health products, as by law many products can only be sold through this channel. Non-store retailing, on the other hand, accounted for less than one fifth of the total distribution share, largely represented by direct selling, although the share of this channel grew rapidly over the review period. Sports nutrition, weight management products, vitamins and dietary supplements and wound care are among the few product types that can be sold outside chemists/pharmacies at the end of the review period.

Consumer health is to register growth over the forecast period

Over the forecast period, consumer health is expected to register positive constant value growth, compared to constant value declines seen over the review period. Improved economic conditions, increasing urbanisation and the structural changes brought about by the expected OTC legislation in the early forecast period will be the main factors driving growth.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Turkey with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Turkey, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Turkey for free:

The Consumer Health in Turkey market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Turkey?
  • What are the major brands in Turkey?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Turkey - Industry Overview

EXECUTIVE SUMMARY

Consumer health demonstrates positive growth in 2011

Long-awaited OTC legislation is still to be introduced

Multinational companies lead

Chemists/pharmacies is the dominant distribution channel

Consumer health is to register growth over the forecast period

KEY TRENDS AND DEVELOPMENTS

Improved economic conditions benefit the consumer health industry

The long-awaited OTC legislation is to expand consumer health

Increasing life expectancy in the Turkish population

Rapid urbanisation in the country is a significant factor behind growth

Production of generics by local companies stimulates growth

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Turkey - Company Profiles

Abdi Ibrahim Ilaç Sanayi ve Ticaret AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Abdi Ibrahim Ilaç Sanayi ve Ticaret AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 6 Abdi Ibrahim Ilaç Sanayi ve Ticaret AS: Competitive Position 2011

Berko Ilac ve Kimya Sanayi AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 Berko Ilac ve Kimya Sanayi AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 10 Berko Ilac ve Kimya Sanayi AS: Competitive Position 2011

Betasan AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Betasan AS: Competitive Position 2011

Biota Laboratuvarlari in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 15 Biota Laboratuvarlari: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 16 Biota Laboratuvarlari: Competitive Position 2011

Kurtsan Ilaclari AS in Consumer Health (Turkey)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 Kurtsan Ilaclari AS: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 20 Kurtsan Ilaclari AS: Competitive Position 2011

Adult Mouth Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, adult mouth care registered 1% current value growth, which was higher than the CAGR registered over the review period. This was mainly due to the improved economic conditions in the country in the last two years of the review period. Payments for products within the adult mouth care category are not reimbursed by the Government, thus people have to purchase them from their own pockets. As a result, economic conditions in the country play a significant role in the performance of the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Kansuk Lab San Ve Tic AS remained dominant in adult mouth care with its Biokadine brand, which is one of the few brands sold without a prescription in the country. This is a relatively well-established brand and offers a range of functionality, as it is recommended as adult mouth care but is also suitable for the easing of teething pain for babies. This brand also serves as a disinfectant for skin. In 2011, the share of Kansuk remained unchanged from the previous year.

PROSPECTS

  • Adult mouth care products that are sold without a prescription are predicted to register a constant value decline of 16% over the forecast period as a whole. However, this decline will be lower than the 32% constant value decline seen over the review period. This is a relatively mature category and is the focus of little or no investment, which serves to prevent its growth. However, the introduction of the long-awaited OTC legislation could provide a stimulus for growth, as more brands may switch to non-prescription. In terms of the existing brands, growth prospects are minimal for the forecast period.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, only some topical analgesics/anaesthetic products were allowed to be sold without a prescription; all other forms of analgesics were sold with a prescription, according to the law. In practice, it is possible to purchase all types of analgesics, except the ones sold with a green prescription (such as morphine) or a red prescription (narcotics), without a prescription when paying. However, by law all analgesics have the warning “sold with prescription” on their packaging. This excludes some topical analgesics, which makes it the only product type present within the OTC analgesics category.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Sanli Ilac Sanayi as was the leading company with its Sanli Yaki topical analgesic patches. Sanli Yaki is an established brand and is sold through chemists/pharmacies and the internet.

PROSPECTS

  • Over the forecast period, the analgesics category is expected to register a higher constant value growth rate, at 4%, than was seen during the review period. This will be due to the increased number of products on offer in the category. OTC legislation is expected to be launched over the forecast period, which will mean that there will be switches from prescription to OTC, translating into a larger pool of products and increased sales in the category.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, calming and sleeping products sold without prescription registered a higher current value growth rate compared to the review period average. Improved economic conditions were the main reason for this growth, simply enabling more to afford to buy these products. Additionally, an increase in stressful lifestyles due to rising urbanisation was another important factor behind growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Sandoz Ilac ve Tic AS continued to hold the leading position with its Passiflora Surup brand. Sandoz took over the Passiflora Surup brand from Ilsan-Iltas AS which ceased operations in 2005. The share of Sandoz fell from 90% in 2008 to 75% in 2011 as it lost share to Farmavita Ilac, which entered the category in 2009.

PROSPECTS

  • Over the forecast period, the calming and sleeping category is expected to register slight constant value growth, compared to the 5% annual decline recorded over the review period. Improved economic conditions will lead to higher disposable incomes, meaning that consumers will be better able to afford to pay for these products from their own pockets. Another important determinant of growth will be rising urbanisation, leading to more stressful and busier lifestyles. As stress has become an inevitable outcome of modern urban life, and has been identified as a major source of many health problems, demand for calming and sleeping products is likely to grow over the forecast period.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, cough, cold and allergy (hay fever) remedies registered better value growth compared to the review period CAGR. Improved economic conditions were a significant factor for growth as people could afford to pay for these products. Another factor for growth was the Government’s new policy of reimbursing for medicines. In 2010, SGK introduced new fees associated with the reimbursement of pharmaceuticals, including a fixed cost for every prescription. This cost discouraged patients from having their prescription written by a doctor, especially for cheaper products and when only a few products are to be included in the prescription. Patients are now more willing to pay directly for such products, especially when the symptoms are familiar and mild, and there is no mention of any epidemic in the media. This willingness of patients to pay for their own products increases the chances of non-prescription alternatives, especially those with lower prices that are still subject to competition from UTC sales of prescription products, particularly when cheaper generic alternatives are available.

SWITCHES

COMPETITIVE LANDSCAPE

  • Kurtsan Ilaclari AS held the leading position within cough, cold and allergy (hay fever) remedies in 2011. It is one of the most well-established companies in the Turkish pharmaceuticals industry. Furthermore, the company is also the owner of the Otaci brand, under which it offers herbal medicated confectionery products. Kurtsan Ilaclari is also the owner of the Oka-Mentol Pastil brand, present under pharyngeal preparations, and the Bugusan brand, within inhalant decongestants. Having a presence across a number of categories made the position of Kurtsan Ilaclari stronger.

PROSPECTS

  • Over the forecast period, the cough, cold and allergy (hay fever) remedies category is expected to register slight constant value growth, compared to a negative performance over the review period. The growth will be driven by nasal sprays. Improved economic conditions will mean that people will be able to afford to pay for these products.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 35 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 36 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 37 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, digestive remedies demonstrated strong current value growth. The stress caused by increasingly busy daily lives, largely as a result of rising urbanisation, translates into digestion-related health problems for many people. Products within the digestive remedies category are generally not reimbursed by the state social security, thus consumer purchasing power dictates the level of demand for non-reimbursement products. Improved economic conditions therefore resulted in positive value growth at the end of the review period compared to the weaker current value performance earlier in the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Bayer Türk Kimya Sanayi Ltd Sti retained the leading position and registered the highest share increase. The company increased its value share by one percentage point to reach 88%. The company owns two of the leading brands within digestive remedies, namely Talcid and Rennie, which are antacids that are very well-known among consumers and widely recommended by chemists/pharmacists.

PROSPECTS

  • Over the forecast period, the digestive remedies category is expected to demonstrate positive constant value growth with a CAGR of 5%, compared to the annual decline of 1% it registered over the review period. Improved economic conditions will translate into an increased number of people who can afford to pay for these products from their own pockets.

CATEGORY DATA

  • Table 38 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 39 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 40 Digestive Remedies Company Shares by Value 2007-2011
  • Table 41 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 42 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 43 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • At the end of the review period, by law all ear care products had to be sold with a prescription. Thus, there are no OTC sales of ear care in Turkey.

Eye Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • At the end of the review period, by law all eye care products had to be sold with a prescription. Thus, there are no OTC sales of eye care in Turkey.

Herbal/Traditional Products in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, many herbal/traditional products faced a significant challenge from standard alternatives (non-herbal/traditional products). Many consumers believe standard products to be more effective as they have stronger formulas. Thus, herbal/traditional products were used only for mild conditions.

COMPETITIVE LANDSCAPE

  • In 2011, the leading companies within the herbal/traditional products category were the local companies Abdi Ibrahim Ilaç Sanayi ve Ticaret AS and Biota Laboratuvarlari, with 22% and 20% value shares, respectively. The strength of both companies stemmed from their first and second rankings within herbal/traditional medicated skin care. Abdi Ibrahim was strong with its Hametan brand, present within paediatric herbal/traditional medicated skin care, while Biota Laboratuvarlari was strong with its Bioxcin brand, present within hair loss treatments.

PROSPECTS

  • Over the forecast period, herbal/traditional products will continue to face significant competition from standard (non-herbal/traditional) products. However, the category will demonstrate a positive performance, registering a 2% constant value CAGR, an improvement on the constant value decline seen over the review period. The improved economic conditions in the country and rising disposable incomes will be the main factors behind growth in the category.

CATEGORY DATA

  • Table 44 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 45 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 46 Herbal/Traditional Products Company Shares 2007-2011
  • Table 47 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 48 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 49 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care faces significant competition from the beauty and personal care industry as a number of products are regarded more as cosmetics than medicine, because of the problems they are designed to solve. Medicated skin care includes products that are bought by consumers as self-medication, rather than treatments for more severe dermatological problems such as eczema or allergies. Substitutes for products in this category are usually cosmetic products rather than medicines.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, local company Biota Laboratuvarlari held the leading position with a 16% value share. The company also saw the largest share increase, up by three percentage points on the previous year. The company gained the leading position within medicated skin care through its strength in the hair loss treatments category. Biota Laboratuvarlari owns the leading hair loss treatments brand, Bioxcin. The company also acquired the Restorex brand from DrMedica Türkiye in 2010, which served to further boost its share in the category.

PROSPECTS

  • Medicated skin care is expected to register a 1% constant value CAGR over the forecast period, compared to a 1% annual decline over the review period. This will be due to improved economic conditions in the country and rising disposable incomes. As payment for the category’s products is not reimbursed by the Government, consumers have to pay from their own pockets, thus improved economic conditions will make these products more affordable.

CATEGORY DATA

  • Table 50 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 51 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 52 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 53 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 54 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 55 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 56 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Turkey - Category Analysis

HEADLINES

TRENDS

  • After the smoking ban in public places was introduced in 2009, the Government has taken further measures to combat smoking. The smoking population in the country rose by 1% in 2011; however, at the same time the number of people who tried quitting smoking also rose. In 2010, the Ministry of Health announced that it will test a newly imported smoking cessation drug and, if it proves to be successful, it will be sold under prescription with reimbursement from SGK. In 2011, the Ministry of Health distributed 250,000 smoking cessation aids and reported that 150,000 people stopped smoking as a result. The Ministry of Health also introduced the Alo 171 quit smoking helpline in November 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, the NRT smoking cessation aids category was very concentrated, with Novartis Saglik Gida ve Tarim Urunleri San ve Ticaret AS’ Nicotinell brand, and Johnson & Johnson Sihhi Malzeme Sanayi ve Ticaret AS’s Nicorette brand accounting for a combined value share of 99%. Novartis had the leading position due to its first mover advantage and higher level of brand recognition among consumers.

PROSPECTS

  • Over the forecast period, the NRT smoking cessation aids category is expected to register positive constant value growth, at a CAGR of 6%. However, this rate will be lower than the 20% constant value CAGR seen in the review period, as the category demonstrated very strong growth from 2009 after the Government implemented the smoking ban. The positive growth in the category will stem from the increasing number of people that wish to stop smoking due to the trend towards healthier lifestyles and the anti-smoking campaigns launched by the Government.

CATEGORY INDICATORS

  • Table 57 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 58 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 59 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 60 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 61 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 62 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 63 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 64 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, sports nutrition saw very strong current value growth that was well above the CAGR registered over the review period. This was a result of the lifting of the ban on the import of products that contain genetically modified organisms (GMO). From 2009 until mid-2010, the import of all products that contained GMO was banned by the Government. This meant that companies could only sell what they had in stock as they could not import new products. However, after the ban was lifted in mid-2010, the category saw very strong growth at the end of the review period. Another reason for the strong growth was the recovery in the economy, leading to higher disposable incomes, which in turn enabled people to purchase these products. Increased availability of sport nutrition products and the fact that increasingly more consumers, particularly men, aim to have a more muscular body is further boosting the category.

COMPETITIVE LANDSCAPE

  • In 2011, General Nutrition Centers Inc (GNC) preserved its leading position within sports nutrition, although the share of the company declined significantly compared with the previous year, falling from 56% in 2010 to 34% in 2011. Many companies, specifically internet retailers, could not import products during the period of the ban (from 2009 until mid-2010), while General Nutrition Centers had the advantage of commanding a large presence in Turkey and holding a large stock. With the lifting of the import ban, however, the company lost share to competitors that sold through the internet, although it still managed to preserve its leading position thanks to its established position and an increase in the number of outlets it operates throughout the country.

PROSPECTS

  • Over the forecast period, sports nutrition is expected to register strong constant value growth, with a CAGR of 9%. However, growth will be slower than that witnessed during the review period. The category saw very strong value growth in 2011 after the lifting of the import ban on products that contain GMO, but during the forecast period the pace of growth is expected to stabilise. The main factors that will lead to positive growth in the category include the expected improvement in the country’s economic conditions, a rise in the number of new products in the category and an increase in the number of websites and retail outlets that offer these products. Furthermore, the number of gyms and sports centres in the country is expected to rise and more people are predicted to engage in exercise, which will also stimulate the growth of sports nutrition.

CATEGORY DATA

  • Table 65 Sales of Sports Nutrition: Value 2006-2011
  • Table 66 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 67 Sports Nutrition Company Shares 2007-2011
  • Table 68 Sports Nutrition Brand Shares 2008-2011
  • Table 69 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 70 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Turkey - Category Analysis

HEADLINES

TRENDS

  • The average life expectancy of people in Turkey is extending. Consumers are taking greater care of their health and wellness, seeking products that offer health benefits such as strengthening their immune systems. Rising urbanisation is contributing to the growth of the vitamins and dietary supplements category since consumers who live in urban areas tend to be better educated and have more knowledge of their daily nutritional needs; they also have higher disposable incomes and greater access to a wider range of products.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Bayer Türk Kimya Sanayi Ltd Sti was the leading company in vitamins and dietary supplements in 2011. It is well established in Turkey and has a strong presence within a number of vitamins and dietary supplements categories. The company led in vitamins and was ranked third in dietary supplements; it was particularly strong within multivitamins with its Supradyn Tb, Elevit Pronatal and One-A-Day range.

PROSPECTS

  • Over the forecast period, the vitamins and dietary supplements category is expected to register a 4% CAGR in constant value terms, a positive performance compared to the constant value decline seen over the review period. Category growth was negatively affected by the adverse economic conditions in the country over the review period. However, in the last year of the review period, improvements in the economy were reflected in the growth of the category. Over the forecast period, the main factors driving the growth of vitamins and dietary supplements will be improved economic conditions, rising urbanisation that leads to better knowledge and awareness of the importance of daily nutritional needs and higher disposable incomes. In addition, life expectancy is rising, which leads people to seek products that strengthen their immune system and support strong joint and bone health.

CATEGORY DATA

  • Table 71 Table: Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 72 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 73 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 74 Dietary Supplements by Positioning 2006-2011
  • Table 75 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 76 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 77 Vitamins Brand Shares by Value 2008-2011
  • Table 78 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 79 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 80 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, the weight management category saw positive value growth, largely driven by the performance of Herbalife International Urunleri Ticaret Ltd Sti, active in meal replacement slimming. The company, which accounts for the bulk of sales in the category, invested heavily in marketing activities in order to raise its sales after the last quarter of 2009. In 2010, the growth it registered was very high, which was reflected in the total sales of meal replacement slimming, making it the most dynamic product type in the last two years of the review period. Weight management saw a higher growth rate in 2011 compared to the review period CAGR as a result of increased marketing activities in the category towards the end of the review period.

COMPETITIVE LANDSCAPE

PROSPECTS

  • Over the forecast period, the weight management category is expected to register positive constant value growth compared to the negative performance seen during the review period. Growth will be driven by the performance of meal replacement slimming, thanks to the rising sales of the dominant Herbalife.

CATEGORY DATA

  • Table 81 Sales of Weight Management: Value 2006-2011
  • Table 82 Sales of Weight Management: % Value Growth 2006-2011
  • Table 83 Weight Management Company Shares 2007-2011
  • Table 84 Weight Management Brand Shares 2008-2011
  • Table 85 Forecast Sales of Weight Management: Value 2011-2016
  • Table 86 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Turkey - Category Analysis

HEADLINES

TRENDS

  • In 2011, wound care registered positive growth, above the average rate seen over the review period, as people started to purchase higher quality and more expensive products in the context of a recovering economy. Growth was supported by product advances, such as sticking plasters that allow air to reach the wound and that are waterproof; higher quality (cotton) gauze and tape; and tape with better quality adhesive.

COMPETITIVE LANDSCAPE

  • In 2011, Betasan AS retained the leading position in wound care. The company operates the Sanitabant, Santavick, Betapore, and Betaipek brands. In 2010, the Sanitabant line was extended with new products such as gelatine plasters and first aid kits. Sanitabant is the most well-established brand within the wound care category, with a widespread presence in the retail outlets.

PROSPECTS

  • Over the forecast period, wound care is expected to see a constant value decline. This is not a dynamic category as these products are relatively mature. However, the rate of decline over the forecast period will be half that registered over the review period. Advances in the category in terms of formats and design will prevent a stronger fall. Companies are expected to widen their range of products in the category. Just as Betasan under its Sanitabant brand introduced first aid kits, other existing companies and new players are expected to follow.

CATEGORY DATA

  • Table 87 Sales of Wound Care by Category: Value 2006-2011
  • Table 88 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 89 Wound Care Company Shares by Value 2007-2011
  • Table 90 Wound Care Brand Shares by Value 2008-2011
  • Table 91 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 92 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!